APA (7th ed.) Citation

Bergmann, L., Maute, L., Heil, G., Rüssel, J., Weidmann, E., Köberle, D., . . . Richly, H. (2015). A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research–EWIV. European Journal of Cancer, 51(1), 27. https://doi.org/10.1016/j.ejca.2014.10.010

Chicago Style (17th ed.) Citation

Bergmann, L., et al. "A Prospective Randomised Phase-II Trial with Gemcitabine Versus Gemcitabine Plus Sunitinib in Advanced Pancreatic Cancer: A Study of the CESAR Central European Society for Anticancer Drug Research–EWIV." European Journal of Cancer 51, no. 1 (2015): 27. https://doi.org/10.1016/j.ejca.2014.10.010.

MLA (9th ed.) Citation

Bergmann, L., et al. "A Prospective Randomised Phase-II Trial with Gemcitabine Versus Gemcitabine Plus Sunitinib in Advanced Pancreatic Cancer: A Study of the CESAR Central European Society for Anticancer Drug Research–EWIV." European Journal of Cancer, vol. 51, no. 1, 2015, p. 27, https://doi.org/10.1016/j.ejca.2014.10.010.